Shanghai Pharmaceuticals Holding Co., Ltd. (02607) has announced the completion of its acquisition of a 10% equity stake in a finance company from Shih East Bund. The transaction, finalized on January 12, 2026, was executed according to the key terms and conditions outlined in the previously disclosed share transfer agreement. Following this acquisition, the company now directly holds a 40% ownership interest in the finance company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments